News
5d
MedPage Today on MSNScreening for Depression and Anxiety in Multiple SclerosisDepression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or ...
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...
Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...
5d
MedPage Today on MSNTolebrutinib Benefits Non-Relapsing Secondary Progressive Multiple SclerosisInvestigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...
Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...
For Pree, diagnosed with multiple sclerosis at 19, finishing college was a challenge. Still, amidst it all, she decided to open up about her journey by sharing her first video on YouTube. Little did ...
Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.
1d
News-Medical.Net on MSN2025 Best Practices Update released for managing MS in a changing landscapeKeeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS).
Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It ... Dec. 18, 2024 — Many ...
Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...
A University of Alberta study shows that rural Albertans living with multiple sclerosis are not as likely as urban patients ...
A man with multiple sclerosis (MS) is about to undertake a feat of physical and mental endurance. Dominic Shadbolt, 53, from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results